Comparing effectiveness of polydeoxyribonucleotide injection and corticosteroid injection in plantar fasciitis treatment: A prospective randomized clinical study. Issue 6 (August 2020)

• Record Type: Journal Article
• Authors: Lee, Dong-Oh; Yoo, Jeong-Hyun; Cho, Hyung-In; Cho, Soonghwan; Cho, Hyung Rae
• Is Part Of: Foot and ankle surgery. Volume 26:Issue 6(2020)
• Page Start: 657
• Page End: 661
• Publication Date: 2020-08
• Subjects: Plantar fasciitis -- Conservative treatment -- Injection -- Polydeoxyribonucleotide (PDRN) -- Corticosteroid; Foot -- Surgery -- Periodicals; Ankle -- Surgery -- Periodicals; Ankle -- surgery -- Periodicals; Foot -- surgery -- Periodicals; Ankle -- Surgery; Foot -- Surgery; Periodicals; Electronic journals; 617.58
• DOI: 10.1016/j.fas.2019.08.005
• Languages: English
• ISSNs: 1268-7731

Abstract

Abstract: Background: This study aimed to compare the efficacy and safety of polydeoxyribonucleotide (PDRN) injection and corticosteroid injection for plantar fasciitis. Methods: This study included 44 patients with plantar fasciitis, randomly allocated to the PDRN and corticosteroid groups. Evaluation using the visual analogue scale (VAS) pain score and Manchester-Oxford foot questionnaire (MOXFQ) was conducted at baseline, 1, 2, 6 weeks and 6 months. The thickness and echogenicity of the plantar fascia in ultrasonography and complications were recorded. Results: Corticosteroid injection elicited more pain relief than did PDRN injection at 2 (p = 0.010) and 6 weeks (p = 0.016); however, it showed no superiority at 6 months (p = 0.523). MOXFQ showed similar outcomes. The thickness and echogenicity did not differ between groups and no complications were reported in either group. Conclusions: We demonstrated that PDRN injection could be an effective and safe option for plantar fasciitis and was comparable to corticosteroid injection after 6 months follow up. Level of evidence: II, comparative study.